/

2190.HK

ZYLOXTBClosed

20.98−0.08 −0.38%HKD

HKSE · as of Oct 14, 04:08 ET · 15m delay

Open

21.20

Prev close

21.06

Day range

20.9221.50

52-week range

17.1028.00

Volume

399.55K0.75×

Mkt cap

6.92B

P/E ttm

19.61

Fwd P/E

12.25

EPS ttm

1.07

Div yield

1.19%

Earnings

—

From 52w high

−25.07%

Price Chart

Yahoo Finance · delayed

2190.HKOct 13, 2026O 20.22H 21.14L 20.10C 21.06+0.72 (+3.54%)Vol 1.07M

SMA 5020.70
SMA 20021.65

1Y change −9.85% since Oct 14, 2025 close527 bars loadedTimes in Asia/Hong_KongDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

2190.HK ZYLOXTB · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −3.75%
1 month: +3.44%
3 months: +7.61%
6 months: −10.08%
Year to date: −8.51%
1 year: −12.98%

Valuation & ownership

Market cap: 6.92B
Enterprise value: 5.94B
P/E (ttm): 19.61
Forward P/E: 12.25
PEG ratio: —
Price / book: 1.99
Price / sales (ttm): 5.73
EV / EBITDA: 17.92
EPS (ttm): 1.07
EPS (forward): 1.71
Beta (5y monthly): 0.33
Dividend yield: 1.19%
Payout ratio: 23.61%
Shares outstanding: 322.06M
Float: 175.80M
Short % of float: —
Short ratio (days): —
Held by insiders: 48.07%
Held by institutions: 32.18%
Avg volume (3m): 530.70K
50-day average: 20.70
200-day average: 21.67
52-week change: −12.98%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 51.0
vs 50-day SMA: +1.74%
vs 200-day SMA: −2.73%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.39%
Realised vol (20d, ann.): 29.4%
From 52-week high: −24.79%
From 52-week low: +23.16%

ANR

Analyst Consensus

5 analysts

Consensus

—

Mean target

31.08

+48.12% implied

Low 29.06Median 30.94High 33.13

Recommendation trend

Now5 / 0 / 0
1m ago5 / 0 / 0
2m ago

DES

About ZYLOXTB

Yahoo Finance profile

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.

Sector: Healthcare
Industry: Medical Devices
Employees: 1,214
Headquarters: Hangzhou, China
Website: zyloxtb.com
Officers: Dr. Zhong Zhao Ph.D. Founder, Chairman & CEO
Mr. Yang Xie Executive Director & Senior Vice President
Dr. Zheng Li Executive Director & Senior Vice President

SEAS

Seasonality · 2190.HK

2021–2026 · monthly returns

Strongest month Apr +11.11%Weakest month Feb −9.25%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	7.1	-11.6	6.6	-1.3	-12.6	-9.5	5.2	12.1	1.0	-2.9			−8.9%
2025	-1.7	9.7	28.5	13.8	5.0	9.2	13.9	-3.0	5.7	-2.6	6.0	-8.2	+100.2%
2024	-18.3	-8.9	4.6	8.2	5.3	-9.4	5.0	4.8	18.2	-12.0	0.0	0.5	−7.6%
2023	9.0	0.7	-22.7	27.5	-19.3	11.8	-6.1	-27.8	-7.8	34.7	17.4	0.3	−3.1%
2022	-11.8	-38.6	-6.4	-5.0	-2.7	23.2	-28.4	14.1	-15.5	-9.7	15.3	23.7	−48.6%
2021								-12.9	9.4	-24.8	-18.2	-7.2	−45.7%

INSD

Insider Activity · 2190.HK

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Apr 28, 2026	Li (Zheng)Director (Executive)	—	100K	—
Apr 28, 2026	Ma (Chang'An)Divisional Officer	—	6.3K	—
Apr 28, 2026	Wang (Hongbo)Divisional Officer	—	4.3K	—
Apr 28, 2026	Xie (Yang)Director (Executive)	—	50K	—
Apr 28, 2026	Zhao (Jonathon Zhong)Chief Executive Officer	—	50K	—
Apr 27, 2026	Li (Zheng)Director (Executive)	—	80K	—
Apr 27, 2026	Zhao (Jonathon Zhong)Chief Executive Officer	—	80K	—
Apr 16, 2026	Li (Zheng)Director (Executive)	—	540K	—
Apr 16, 2026	Ma (Chang'An)Divisional Officer	—	12K	—
Apr 16, 2026	Wang (Hongbo)Divisional Officer	—	9K	—
Apr 16, 2026	Xie (Yang)Director (Executive)	—	540K	—
Apr 16, 2026	Zhao (Jonathon Zhong)Chief Executive Officer	—	1.08M	—
Apr 8, 2026	Zhao (Jonathon Zhong)Chief Executive Officer	Other at price 2.68 per share.	3.42M	$9.17M
Dec 30, 2025	Li (Zheng)Director (Executive)	—	30K	—
Dec 30, 2025	Ma (Chang'An)Divisional Officer	—	6.3K	—
Dec 30, 2025	Wang (Hongbo)Divisional Officer	—	4.3K	—
Dec 30, 2025	Xie (Yang)Director (Executive)	—	50K	—
Dec 30, 2025	Zhao (Jonathon Zhong)Chief Executive Officer	—	20K	—
Mar 30, 2025	Li (Zheng)Director (Executive)	—	239.4K	—
Mar 30, 2025	Li (Zheng)Director (Executive)	—	120K	—

2190.HK

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

2190.HK

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About ZYLOXTB

Seasonality · 2190.HK

Insider Activity · 2190.HK

Congress Trades · 2190.HK

Investors Holding 2190.HK

Investors Holding 2190.HK

Congress Trades · 2190.HK

Insider Activity · 2190.HK

Seasonality · 2190.HK

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About ZYLOXTB

Financial Snapshot

Earnings & Dividends

News